D-40
Active substance: PHOSPHORIC ACID, LYCOPODIUM CLAVATUM SPORE, SODIUM SULFATE, CLAVICEPS PURPUREA SCLEROTIUM, URANYL NITRATE HEXAHYDRATE, PHASEOLUS VULGARIS WHOLE, ARSENIC TRIOXIDE
SOLUTION · PHOSPHORIC ACID 12 [hp_X]/mL, LYCOPODIUM CLAVATUM SPORE 30 [hp_X]/mL, SODIUM SULFATE 12 [hp_X]/mL, CLAVICEPS PURPUREA SCLEROTIUM 4 [hp_X]/mL, URANYL NITRATE HEXAHYDRATE 30 [hp_X]/mL, PHASEOLUS VULGARIS WHOLE 12 [hp_X]/mL, ARSENIC TRIOXIDE 8 [hp_X]/mL
United StatesActive
Marketing holder: DNA Labs, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PHOSPHORIC ACID · 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE · 30 [hp_X]/mL
- SODIUM SULFATE · 12 [hp_X]/mL
- CLAVICEPS PURPUREA SCLEROTIUM · 4 [hp_X]/mL
- URANYL NITRATE HEXAHYDRATE · 30 [hp_X]/mL
- PHASEOLUS VULGARIS WHOLE · 12 [hp_X]/mL
- ARSENIC TRIOXIDE · 8 [hp_X]/mL
Registration
- Registration number
- 58264-0040
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 58264-0040 · Verified 2026-10-09 · open in source